Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
BIGTINCAN HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 0.1700 AUD | -5.56% | +6.25% | -67.92% | |
| Nov. 15 | Bigtincan Holdings Limited Provides Earnings Guidance for the Fiscal Year 2024 | CI |
| Oct. 03 | Bigtincan Holdings Limited Announces Resignation of Farouk Hussein as Non-Executive Director | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Sales 2024 * | 135 M 89.84 M | Sales 2025 * | 145 M 96.39 M | Capitalization | 109 M 72.71 M |
|---|---|---|---|---|---|
| Net income 2024 * | 2.00 M 1.33 M | Net income 2025 * | 8.00 M 5.32 M | EV / Sales 2024 * | 0,58x |
| Net cash position 2024 * | 31.03 M 20.64 M | Net cash position 2025 * | 35.16 M 23.39 M | EV / Sales 2025 * | 0,51x |
| P/E ratio 2024 * | - | P/E ratio 2025 * | 12,9x | Employees | 495 |
| Yield 2024 * | - | Yield 2025 * | - | Free-Float | 0.00% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -5.56% | ||
| 1 week | +6.25% | ||
| Current month | -38.18% | ||
| 1 month | -35.85% | ||
| 3 months | -59.52% | ||
| 6 months | -69.64% | ||
| Current year | -67.92% |
1 week
0.15
0.19
1 month
0.150.31
Current year
0.150.65
1 year
0.150.78
3 years
0.151.53
5 years
0.151.60
10 years
0.151.60
| Managers | Title | Age | Since |
|---|---|---|---|
David Keane
FOU | Founder | - | 2010 |
Patrick Welch
PSD | President | - | 2011 |
Vivian Stewart
COO | Chief Operating Officer | - | 2017 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Inese Kingsmill
BRD | Director/Board Member | - | 2021 |
Wayne Stevenson
BRD | Director/Board Member | - | 2016 |
David Keane
FOU | Founder | - | 2010 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.24% | 103 M€ | +20.77% | ||
| 0.01% | 589 M€ | +2.40% | - | |
| 0.00% | 14,684 M€ | +9.58% | - | |
| 0.00% | 204 M€ | +5.48% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-11-28 | 0.1700 | -5.56% | 837 227 |
| 23-11-27 | 0.1800 | 0.00% | 1,559,387 |
| 23-11-24 | 0.1800 | +24.14% | 3,054,658 |
| 23-11-23 | 0.1450 | 0.00% | 2,119,965 |
| 23-11-22 | 0.1450 | -3.33% | 3,418,906 |
Delayed Quote Australian Stock Exchange, November 28, 2023 at 12:10 am EST
More quotes
Beta Pharmaceutical Limited is a Australia-based biopharmaceutical company. The Company is focused on the identification, development and commercialization of products and therapies targeting the chemoprevention and treatment of breast cancer. The Company is working in collaboration with scientists at the College of Pharmacy, University of Louisiana at Monroe in southern the United States of America (ULM) to develop cancer chemopreventive agents using natural phytonutrients, called tocotrienols as treatments for breast cancers. Funded by Beta Pharmaceutical Limited, the applied research programme with ULM includes four laboratories and is known as the Breast Cancer and Health Project, which has been underway.
Calendar
05:30pm
- Annual General Meeting
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.1700AUD
Average target price
0.5650AUD
Spread / Average Target
+232.35%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| -67.92% | 72 M $ | |
| +66.54% | 40 453 M $ | |
| +3.91% | 38 458 M $ | |
| -56.86% | 29 633 M $ | |
| -25.31% | 29 066 M $ | |
| +40.10% | 22 180 M $ | |
| -32.31% | 19 978 M $ | |
| +2.80% | 17 370 M $ | |
| -17.38% | 10 860 M $ | |
| -9.76% | 9 987 M $ |